2001
DOI: 10.1053/meta.2001.26709
|View full text |Cite
|
Sign up to set email alerts
|

Effect of norepinephrine on the urinary excretion of purine bases and oxypurinol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
32
0
2

Year Published

2003
2003
2014
2014

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 38 publications
(36 citation statements)
references
References 15 publications
2
32
0
2
Order By: Relevance
“…Serum triglycerides and n-6 PUFAs (measured from red blood cell membranes) predict approximately one-third of the variance in SUA in healthy volunteers [51]. There is also evidence that NE exerts a modulatory effect on SUA, as administration of NE to healthy volunteers decreased SUA levels in urine [52]. In schizophrenics, evidence suggests that SUA is decreased at baseline compared to healthy controls, and that haloperidol (a dopaminergic antipsychotic) raises SUA levels in schizophrenics [53].…”
Section: Endogenous Antioxidants Correlated With Cretive Ability Are mentioning
confidence: 99%
“…Serum triglycerides and n-6 PUFAs (measured from red blood cell membranes) predict approximately one-third of the variance in SUA in healthy volunteers [51]. There is also evidence that NE exerts a modulatory effect on SUA, as administration of NE to healthy volunteers decreased SUA levels in urine [52]. In schizophrenics, evidence suggests that SUA is decreased at baseline compared to healthy controls, and that haloperidol (a dopaminergic antipsychotic) raises SUA levels in schizophrenics [53].…”
Section: Endogenous Antioxidants Correlated With Cretive Ability Are mentioning
confidence: 99%
“…Recently it has been reported that fenofibrate, one of the fibrates, has the effects that are observed in the fibrate class agents and the anti-hyperuricemic effect (14)(15)(16). Some authors report that the anti-hyperuricemic effect of fenofibrate comes from its uricosuric action (17). There are several reports on the anti-hyperuricemic effect of fenofibrate as mentioned above, and the reports are focused on the hyperuricemic patients or healthy volunteers.…”
Section: Introductionmentioning
confidence: 99%
“…In hyperlipidemic patients, fenofibrate (300 mg/day) for 12 weeks decreased serum uric acid concentration by 36% and increased fractional uric acid clearance by 62% [62]. Three days' administration of fenofibrate 450 mg increased fractional clearance of uric acid, compared to baseline value, while the plasma concentration decreased in normal subjects [63]. Mechanism by which fenofibrate decreases serum uric acid levels by increasing its urinary excretion is considered to be through the inhibition of URAT1 by fenofibric acid, major metabolite of fenofibrate [64].…”
Section: Fenofibratementioning
confidence: 94%